Effects of topically applied capsaicin cream on neurogenic inflammation and thermal sensitivity in rats

Japanese Journal of Pharmacology

Volumn 82, Issue 2, 2000, Pages 116-121

  Yoshimura, Masakazu ^a   Yonehara, Norifumi ^b   Ito, Takashi ^b   Kawai, Yoichiro ^a   Tamura, Takashi ^a  

^a Maruishi Pharmaceutical Co Ltd   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Analgesic; Capsaicin cream; Neurogenic inflammation; Substance P

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; CAPSAICIN; EVANS BLUE; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; SAREDUTANT; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEVICE; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG INHIBITION; ELECTROSTIMULATION; HEAT SENSITIVITY; HYPERALGESIA; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; PAIN; PAIN THRESHOLD; RAT; SCIATIC NERVE; TECHNICAL AID; THERMAL STIMULATION;

EID: 0034069322     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.82.116     Document Type: Article

References (25)

1. Buck SH and Burks TF: The neuropharmacology of capsaicin: Review of some recent observation. Pharmacol Rev 38, 179-226 (1986)
2. Jancsó N, Jancsó-Gábor A and Szolcsányi J: Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 31, 138-151 (1967)
3. Burnstein JE, Swift RM, Soltant K and Lorincz AL: Inhibition of axon reflex vasodilation by topically applied capsaicin. J Invest Dermat 76, 394-395 (1981)
4. Jessll TM, Iversen LL and Cuello AC: Capsaicin-induced depletion of substance P from primary sensory neurons. Brain Res 152, 183-188 (1978)
5. Lynn B, Ye W and Costell B: The action of capsaicin applied topically to the skin of the rat on C-fiber afferents, antidromic vasodilation and substance P levels. Br J Pharmacol 107, 400-406 (1992)
6. Bucci FA, Gabriels CF and Krohel GB: Successful treatment of post-herpetic neuralgia with capsaicin. Am J Ophthalmol 106, 758-759 (1988)
7. Bernstein JE, Bickers DR, Dahl MV and Roshal JY: Treatment of chronic postherpetic neuralgia with topical capsaicin. J Am Acad Dermatol 17, 93-96 (1987)
8. Watson CPN, Evans RJ and Watt VR: Post-herpetic neuralgia and topical capsaicin. Pain 33, 333-340 (1988)
9. Bernstein JE, Korman NJ, Bickers DR, Dahl MV and Millikan LE: Topical capsaicin treatment of postherpetic neuralgia. J Am Dermatol 21, 265-270 (1989)
10. Ross DR and Varipapa RJ: Treatment of painful diabetic neuropathy with topical capsaicin. N Engl J Med 321, 474-475 (1989)
11. Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Mihitch M, Shipper HM, Stall G, Dyess E and Tarsy D: Does capsaicin relieve the pain of diabetic neuropathy? Pain 42, 387-388 (1990)
12. Yonehara N, Shibutani T, Tsai H-Y and Inoki R: Effects of opioids and opioid peptide on the release of substance P-like material induced by tooth pulp stimulation in the trigeminal nucleus caudalis of the rabbit. Eur J Pharmacol 129, 209-216 (1986)
13. Yonehara N, Shibutani T and Inoki R: Contribution of substance P to heat-induced edema in rat paw. J Pharmacol Exp Ther 242, 1071-1076 (1987)
14. Yonehara N, Imai Y and Inoki R: Influence of heat stimulation on the amount of calcitonin gene-related peptide and neurokinin A in the subcutaneous space of the rat hind instep. Jpn J Pharmacol 56, 381-384 (1991)
15. Yonehara N, Chen J-Q, Imai Y and Inoki R: Involvement of substance P present in primary afferent neurons in modulation of cutaneous blood flow in the instep of rat hind paw. Br J Pharmacol 106, 256-262 (1992)
16. Yonehara N, Saito K, Oh-ishi S, Katori M and Inoki R: Contribution of bradykinin to heat-induced substance P release in the hind instep of rats. Life Sci 56, 1679-1688 (1995)
17. Hayes AG, Scadding JW, Skingle M and Tyers MB: Effects of neonatal capsaicin on nociceptive thresholds in the mouse and rat. J Pharm Pharmacol 33, 183-185 (1981)
18. Hayes AG, Skingle M and Tyers MB: Effects of single doses of capsaicin on nociceptive thresholds in the rodent. Neuropharmacology 20, 505-511 (1981)
19. Perkins MN and Campbell EA: Capsazepine reversal of the antinociceptive action of capsaicin in vivo. Br J Pharmacol 107, 329-333 (1992)
20. McMahon SB, Lewin G and Bloom SR: The consequences of long-term topical capsaicin application in the rat. Pain 44, 301-310 (1991)
21. Carter RB and Francis WR: Capsaicin desensitization to plasma extravasation evoked by antidromic C-fiber stimulation is not antinociception in the rat. Neurosci Lett 127, 43-45 (1991)
22. Bjerring P and Arendt-Nielsen L: Use of a new argon laser technique to evaluate changes in sensory and pain thresholds in human skin following topical capsaicin treatment. Skin Pharmacol 2, 162-167 (1989)
23. Bittner MA and Lahann TR: Biphasic time-course of capsaicin-induced substance P depletion: failure to correlate with thermal analgesia in the rat. Brain Res 322, 305-309 (1984)
24. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD and Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816-824 (1997)
25. Bevan S and Szolcsányi J: Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci 11, 330-333 (1990)